Treatment application of rivaroxaban in Chinese patients with livedoid vasculopathy

Treatment application of rivaroxaban in Chinese patients with livedoid vasculopathy

Wenji Chen,1 Lina Fan,1 Yanyan Wang,2 Xiaohu Deng2 1Department of Rheumatology, Hainan Branch of Chinese People’s Liberation Army General Hospital, Sanya, 2Department of Rheumatology, Chinese People’s Liberation Army General Hospital, Beijing, People’s Republic of China...

Full description

Bibliographic Details
Main Authors:	Chen W, Fan L, Wang Y, Deng XH
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-03-01
Series:	Journal of Pain Research
Subjects:	livedoid vasculopathy rivaroxaban
Online Access:	https://www.dovepress.com/treatment-application-of-rivaroxaban-in-chinese-patients-with-livedoid-peer-reviewed-article-JPR

Similar Items

Ulcerative livedoid vasculopathy responding to clopidogrel
by: Elaine Kunzler, BS, et al.
Published: (2018-03-01)

Livedoid vasculopathy with hyperhomocysteinemia responding to hyperbaric oxygen therapy
by: Rahul Ray, et al.
Published: (2015-01-01)

Use of low-dose oral warfarin in three cases of livedoid vasculopathy
by: Vikrant Saoji, et al.
Published: (2017-01-01)

Livedoid vasculopathy with mononeuritis multiplex associated with protein S deficiency mimicking systemic vasculitis
by: Vikramraj K Jain, et al.
Published: (2019-01-01)

A case of ulcerative livedoid vasculopathy treated successfully with pentoxifylline and colchicine
by: Farheen Kahkashan Ahmed, et al.
Published: (2020-12-01)

Primary livedoid vasculopathy with livedo reticularis: a report of a case successfully treated with cyclosporine and dapsone
by: Galal El Enany, et al.
Published: (2021-01-01)

Livedoid Vasculopathy and Mononeuritis Multiplex, with a Fulminant Hepatic Failure which was caused by Herpes Simplex Hepatitis: A Case Report
by: Sathish Pai B, et al.
Published: (2013-05-01)

Ulceration in Prolidase Deficiency: Successful Treatment with Anticoagulants
by: Kira Süßmuth, et al.
Published: (2020-01-01)

Microangiopatia livedóide associada à síndrome do anticorpo antifosfolípide (SAF) Livedoid microangiopathy associated to antiphospholipid antibody syndrome (APS)
by: Carla Munhoz Sanches, et al.
Published: (2005-12-01)

Livedoid vasculopathy - a challenging disease
by: Romana Vieira, et al.
Published: (2016-07-01)

The use of a topical compound cream product with Chitosan, Silver Sulfadiazine Bentonite hidrogel and Lactic acid for the treatment of a patient with Rosacea and ulcerated Livedoid Vasculopathy
by: Alin Laurentiu Tatu
Published: (2015-10-01)

Diclofenac sodium-induced livedoid dermatitis (Nicolau syndrome) in an obese patient
by: Galal El Anany, et al.
Published: (2019-01-01)

Dermatopatología de la oclusión intraluminal vascular: parte II (coagulopatías, émbolos y miscelánea)
by: M.J. Beato Merino, et al.
Published: (2021-02-01)

Hemomediastino en tomador de rivaroxaban
by: Pablo Ruiz-Sada, et al.
Published: (2016-12-01)

Livedoid vasculopathy
by: José Roberto Provenza, et al.

Livedoid vasculopathy
by: Thiago Quadrante Freitas, et al.
Published: (2018-08-01)

Intracranial hemorrhage in patient treated with rivaroxaban
by: Michelle Molina, et al.
Published: (2014-03-01)

NOVEL APPROACH TO ANTITHROMBOTIC TREATMENT OF ACUTE CORONARY PATIENTS WITH RIVAROXABAN
by: I. N. Bokarev, et al.
Published: (2015-07-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
by: Kapil G. Kapoor, et al.
Published: (2015-12-01)

Bayer registered a new indication for rivaroxaban for use in patients with coronary heart disease or peripheral artery disease in the European Union and USA
by: Bayer Company Press Release
Published: (2018-11-01)

Treatment Outcomes in Patients with Polypoidal Choroidal Vasculopathy
by: Mümin Hocaoğlu, et al.
Published: (2016-01-01)

Large vessel vasculopathy in a patient with systemic lupus erythematosus: a case report
by: Daisuke Waki, et al.
Published: (2019-06-01)

A study on the role of rivaroxaban in management of venous thromboembolism
by: Mohmed Abdalwahab, et al.
Published: (2015-10-01)

Prospects of rivaroxaban application in treatment of patients with chronic ischemic heart disease
by: N. B. Perepech
Published: (2020-01-01)

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
by: Rupert Bauersachs, et al.
Published: (2020-05-01)

RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov
Published: (2015-12-01)

The Vasculopathy of Juvenile Dermatomyositis
by: Charalampia Papadopoulou, et al.
Published: (2018-10-01)

VASCULOPATHY IN SYSTEMIC SCLEROSIS
by: Iolanda Panaitiu, et al.
Published: (2016-06-01)

Rivaroxaban for the treatment of cerebral venous thrombosis
by: Sara Esmaeili, et al.
Published: (2021-02-01)

Laboratory monitoring of rivaroxaban in Chinese patients with deep venous thrombosis: a preliminary study
by: Ying Li, et al.
Published: (2020-05-01)

SPONTANEOUS SPLENIC RUPTURE SECONDARY TO RIVAROXABAN: RARE BUT RAISING
by: Zainab Naseem, et al.
Published: (2016-08-01)

What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
by: Kobashigawa Jon
Published: (2000-12-01)

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
by: Jan Beyer-Westendorf, et al.
Published: (2019-04-01)

Livedoid Vasculopathy: diagnosis and treatment in pregnant women
by: Alexandre Sacchetti Bezerra, et al.

Progress in treatment of submacular hemorrhage due to polypoid choroidal vasculopathy
by: Shuang Zhang, et al.
Published: (2019-06-01)

Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations
by: A.V. Fonyakin, et al.
Published: (2014-05-01)

Nicolau syndrome: A rarely seen iatrogenic fatal cutaneous reaction following intramuscular diclofenac injection
by: Anup Kumar Tiwary, et al.
Published: (2016-01-01)

Generalized livedo reticularis like eruption induced Generalized livedo reticularis like eruption induced by trimethoprim/sulfamethoxazole: A case report with by trimethoprim/sulfamethoxazole: A case report with concomitant myelosuppression
by: Pinar Incel Uysal, et al.
Published: (2017-10-01)

A Phase II Multicenter Trial With Rivaroxaban in the Treatment of Livedoid Vasculopathy Assessing Pain on a Visual Analog Scale
by: Drabik, Attyla, et al.
Published: (2014-12-01)

Cannot write session to /tmp/vufind_sessions/sess_iu8oe1cj1e4hd17jo1snvo7r7u